📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Tisagenlecleucel in adult relapsed or refractory follicular lymphoma: the phase 2 ELARA trial. (2022)

First Author: Fowler NH

Attributed to: Evaluation of the CD4+ T cell tumour microenvironment of low grade B cell lymphoproliferative disorders funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1038/s41591-021-01622-0

PubMed Identifier: 34921238

Publication URI: http://europepmc.org/abstract/MED/34921238

Type: Journal Article/Review

Volume: 28

Parent Publication: Nature medicine

Issue: 2

ISSN: 1078-8956